Please login to the form below

Not currently logged in
Email:
Password:

pioglitazone

This page shows the latest pioglitazone news and features for those working in and with pharma, biotech and healthcare.

Kinarus’ KIN001 shows strong antiviral activity against BA.2 and BA.5 Omicron subvariants

Kinarus’ KIN001 shows strong antiviral activity against BA.2 and BA.5 Omicron subvariants

KIN001 is an orally administered combination of two drugs – pamapimod and pioglitazone – that have demonstrated synergistic antiviral and anti-inflammatory activity, as well as ability to reduce tissue fibrosis, a quality

Latest news

More from news
Approximately 5 fully matching, plus 70 partially matching documents found.

Latest Intelligence

  • Interview: Trevor Smith, Takeda Interview: Trevor Smith, Takeda

    Ulcer drug lansoprazole and prostate cancer treatment leuprorelin already faced generic competition and before the deal was completed Takeda's diabetes drug Actos (pioglitazone) lost exclusivity in January 2011.

  • Country report: The healthcare market in Japan Country report: The healthcare market in Japan

    to its multi-billion dollar main product, the antidiabetic Actos (pioglitazone), in August. ... Takeda's patent on the blockbuster Actos (pioglitazone) for type 2 diabetes expired in January, but an agreement with generic drugmakers Ranbaxy, Watson and

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...